The estimated Net Worth of Michael F Brigham is at least $1.13 Milión dollars as of 28 December 2018. Mr Brigham owns over 47,500 units of Immucell stock worth over $776,010 and over the last 21 years he sold ICCC stock worth over $0. In addition, he makes $354,272 as Pres, CEO, Principal Financial Officer, Treasurer a Sec. & Director at Immucell.
Mr has made over 12 trades of the Immucell stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 47,500 units of ICCC stock worth $80,750 on 28 December 2018.
The largest trade he's ever made was buying 51,000 units of Immucell stock on 27 February 2009 worth over $66,810. On average, Mr trades about 7,056 units every 275 days since 2003. As of 28 December 2018 he still owns at least 204,752 units of Immucell stock.
You can see the complete history of Mr Brigham stock trades at the bottom of the page.
Michael F. Brigham is the Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director at Immucell.
As the Pres, CEO, Principal Financial Officer, Treasurer a Sec. & Director of Immucell, the total compensation of Mr Brigham at Immucell is $354,272. There are no executives at Immucell getting paid more.
Mr Brigham is 60, he's been the Pres, CEO, Principal Financial Officer, Treasurer a Sec. & Director of Immucell since . There are 6 older and 5 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND, ME, 04103.
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin a Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
Immucell executives and other stock owners filed with the SEC include: